When did GILD join the S&P 500?

Gilead Sciences joined the S&P 500 index on 2004-07-01.

What sector is GILD in?

GILD is in the Health Care sector, Biotechnology industry.

GILD — Gilead Sciences

Name: GILD Institutional Holdings (13F) — 2026Q1
Creator: SEC EDGAR
License: https://www.sec.gov/data

Biotechnology · Health Care

S&P 500 Timeline

2004-07-01Joined S&P 500

Gilead Sciences, Inc. is a biopharmaceutical company engaged in the research, development, and commercialization of medicines in areas of unmet medical need. The company's primary focus areas include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, inflammation, and respiratory diseases. It provides antiviral products under the Harvoni, Genvoya, Epclusa, Truvada, Atripla, Descovy, Stribild, Viread, Odefsey, Complera/Eviplera, Sovaldi, and Vosevi brands.

Key Facts

Status	Active
Sector	Health Care
Industry	Biotechnology
Joined	2004-07-01
Tenure	22 yrs

Industry Peers

ABBV AMGN BIIB INCY MRNA REGN VRTX

Sector Peers

A ABBV ABT ALGN AMGN BAX BDX BIIB BMY BSX

Institutional Holdings (13F)

2,306 institutions hold GILD, totaling 1.33B shares ($170.5B) · As of 2026Q1

Rank	Institution	Shares	Value
1	VANGUARD CAPITAL MANAGEMENT LLC	161.3M	$22.5B
2	BlackRock, Inc.	119.0M	$16.6B
3	FMR LLC	71.9M	$10.0B
4	MORGAN STANLEY	70.5M	$8.8B
5	STATE STREET CORP	59.9M	$8.3B
6	BARCLAYS PLC	67.0M	$6.0B
7	Capital World Investors	41.3M	$5.8B
8	VANGUARD PORTFOLIO MANAGEMENT LLC	35.1M	$4.9B
9	JPMORGAN CHASE & CO	34.0M	$4.6B
10	GEODE CAPITAL MANAGEMENT, LLC	29.7M	$4.1B

View all holders →

Data source: Wikipedia · CC BY-SA 4.0 · SEC EDGAR 13F · Updated 2026-07-10